GRAM · Gold Flora Corp. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31.96M | $31.64M | $32.15M | - | $31.96M | $19.41M | $18.05M | - | $19.56M | $27.38M |
| Cost of Revenue | $19.14M | $24.39M | $22.12M | - | $12.13M | $9.98M | $10.27M | - | $12.94M | $49.42M |
| Gross Profit | $13.48M | $7.25M | $10.03M | - | $11.31M | $9.44M | $7.78M | - | $6.62M | $4.78M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $23.01M | $8.67M | $18.97M | - | $5.91M | $13.54M | $7.95M | - | - | $9.11M |
| Total Operating Expenses | $23.01M | $20.77M | $18.97M | - | $25.62M | $29.89M | $22.10M | - | $36.84M | $43.02M |
| D&A | $5.46M | $2.62M | $4.05M | - | $2.03M | - | $5.99M | - | - | $879.9K |
| Operating Income | ($9.53M) | ($13.52M) | ($8.94M) | - | ($14.30M) | ($20.86M) | ($14.32M) | - | ($158.04M) | ($55.10M) |
| Interest Expense | $5.05M | $4.71M | $4.33M | - | $6.83M | $1.21M | $1.26M | - | $1.18M | $1.42M |
| Income Tax | $2.27M | $736.0K | $987.0K | - | $6.81M | ($1.96M) | $714.4K | - | $24.46M | ($131.3K) |
| Net Income | ($18.83M) | ($23.84M) | ($13.63M) | - | $22.96M | ($24.31M) | ($16.51M) | - | ($148.03M) | $5.82M |
| EPS - Basic | ($0.07) | ($0.08) | ($0.05) | - | ($0.09) | - | - | - | - | $0.06 |
| EPS - Diluted | ($0.07) | ($0.15) | ($0.05) | - | $0.08 | - | - | - | - | $0.06 |
Balance Sheet
| Line item | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.17M | $10.68M | $14.22M | $22.54M | $32.30M | $60.54M | $76.11M | $93.70M | $107.11M | $257.54M |
| Accounts Receivable | $4.74M | $2.20M | $2.85M | $1.77M | $2.81M | $1.11M | $928.6K | $1.21M | $2.16M | $2.83M |
| Inventory | $18.78M | $18.35M | $20.05M | $18.37M | $15.24M | $6.18M | $6.99M | $8.73M | $15.54M | $19.17M |
| Accounts Payable | $21.18M | $20.84M | $15.49M | $13.34M | $12.59M | $5.98M | $2.54M | $8.09M | $4.94M | $6.23M |
| Current Assets | $46.39M | $43.47M | $51.41M | $52.86M | $58.61M | $81.57M | $99.88M | $118.21M | $141.03M | $168.34M |
| Total Assets | $209.69M | $208.40M | $220.61M | $226.37M | $277.13M | $237.86M | $258.80M | $280.52M | $322.59M | $492.30M |
| Current Liabilities | $110.60M | $93.29M | $97.15M | $87.73M | $80.06M | $37.96M | $33.54M | $36.70M | $41.68M | $45.05M |
| Long-term Debt | - | - | - | $28.22M | - | - | - | - | - | - |
| Total Liabilities | $273.12M | $253.03M | $241.38M | $233.61M | $243.05M | $115.56M | $112.63M | $119.48M | $127.38M | $151.15M |
| Stockholders' Equity | ($63.31M) | ($44.57M) | ($20.83M) | ($7.38M) | $33.96M | $122.29M | $146.18M | $161.04M | $160.20M | $304.59M |
| Retained Earnings | ($167.13M) | ($148.30M) | ($124.47M) | ($110.83M) | ($68.66M) | ($876.48M) | ($852.17M) | $835.66M | ($804.83M) | ($656.84M) |
Cash Flow
| Line item | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($4.36M) | - | - | - | ($13.64M) | - | - | - |
| Investing Cash Flow | - | - | ($680.0K) | - | - | - | ($2.42M) | - | - | - |
| Financing Cash Flow | - | - | ($3.28M) | - | - | - | ($1.53M) | - | - | - |
| CapEx | - | - | $651.0K | - | - | - | $244.8K | - | - | - |
| Free Cash Flow | - | - | ($5.01M) | - | - | - | ($13.88M) | - | - | - |
Ratios
| Metric | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 42.2% | 22.9% | 31.2% | - | 35.4% | 48.6% | 43.1% | - | 33.8% | 17.5% |
| Operating margin | -29.8% | -42.7% | -27.8% | - | -44.8% | -107.5% | -79.3% | - | -807.9% | -201.3% |
| EBITDA margin | -12.7% | -34.5% | -15.2% | - | -38.4% | - | -46.1% | - | - | -198.1% |
| Net margin | -58.9% | -75.3% | -42.4% | - | 71.8% | -125.2% | -91.4% | - | -756.8% | 21.3% |
| Free cash flow margin | - | - | -15.6% | - | - | - | -76.9% | - | - | - |
| FCF / Net income | - | - | 0.37 | - | - | - | 0.84 | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 72.0% | 27.4% | 59.0% | - | 18.5% | 69.8% | 44.1% | - | - | 33.3% |
| Effective tax rate | - | - | - | - | 22.9% | - | - | - | - | -2.3% |
| Return on assets | -9.0% | -11.4% | -6.2% | - | 8.3% | -10.2% | -6.4% | - | -45.9% | 1.2% |
| Return on equity | 29.7% | 53.5% | 65.5% | - | 67.6% | -19.9% | -11.3% | - | -92.4% | 1.9% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.42 | 0.47 | 0.53 | 0.60 | 0.73 | 2.15 | 2.98 | 3.22 | 3.38 | 3.74 |
| Quick ratio | 0.25 | 0.27 | 0.32 | 0.39 | 0.54 | 1.99 | 2.77 | 2.98 | 3.01 | 3.31 |
| Cash ratio | 0.09 | 0.11 | 0.15 | 0.26 | 0.40 | 1.60 | 2.27 | 2.55 | 2.57 | 5.72 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | -3.82 | - | - | - | - | - | - |
| Debt / Assets | - | - | - | 0.12 | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -1.9x | -2.9x | -2.1x | - | -2.1x | -17.3x | -11.3x | - | -133.5x | -38.8x |
| Equity multiplier | -3.31 | -4.68 | -10.59 | -30.66 | 8.16 | 1.94 | 1.77 | 1.74 | 2.01 | 1.62 |
| Liabilities / Assets | 1.30 | 1.21 | 1.09 | 1.03 | 0.88 | 0.49 | 0.44 | 0.43 | 0.39 | 0.31 |
| Efficiency | ||||||||||
| Asset turnover | 0.15 | 0.15 | 0.15 | - | 0.12 | 0.08 | 0.07 | - | 0.06 | 0.06 |
| Inventory turnover | 1.02 | 1.33 | 1.10 | - | 0.80 | 1.61 | 1.47 | - | 0.83 | 2.58 |
| Days sales outstanding | 54d | 25d | 32d | - | 32d | 21d | 19d | - | 40d | 38d |
| Days inventory outstanding | 358d | 275d | 331d | - | 458d | 226d | 248d | - | 438d | 142d |
| Days payable outstanding | 404d | 312d | 256d | - | 379d | 219d | 90d | - | 139d | 46d |
| Cash conversion cycle | 8d | -12d | 108d | - | 112d | 28d | 177d | - | 339d | 133d |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | 0.8x | 0.5x | 2.7x | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -0.0% | 63.0% | 78.1% | - | 63.4% | -29.1% | -54.8% | - | -50.7% | - |
| Revenue CAGR (3y) | -6.9% | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 19.2% | -23.2% | 28.9% | - | 71.0% | 97.4% | 10.5% | - | 8.7% | - |
| Operating income growth (YoY) | 33.4% | 35.2% | 37.6% | - | 90.9% | 62.1% | 55.8% | - | -42420.9% | - |
| Net income growth (YoY) | - | 2.0% | 17.4% | - | - | - | 50.8% | - | 73.6% | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | 63.9% | - | - | - | 74.2% | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | - | - | -78.8% | -59.8% | -84.8% | -55.4% | - | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2023-12-31.
Business segments
$90.96M totalRetail Segment$78.45M · 86.2%
Wholesale Segment$12.52M · 13.8%
Peer comparison
Same SIC group: Agricultural Production-Crops
| Company | Revenue (last FY) | Net margin | ROE |
|---|---|---|---|
| FDP | $4.32B | 2.1% | 4.5% |
| CTVA | $17.40B | 6.3% | 4.5% |
| VRNO | $821.50M | -31.4% | -36.6% |
| CBSTF | - | - | - |
| GTII/GTBIF | $1.18B | 9.7% | 6.0% |
Comparing Gold Flora Corp. against the 5 most active filers in the same SIC group.